Texas Instruments Incorporated
Texas Instruments Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $17.7 billion, up 13.0% from fiscal 2024.
- Revenue
- +27.7%
- EPS
- +76.7%
- Free cash flow
- +197.4%
- Total debt
- −3.50%
Quarter to September 2026, against a year earlier
Follow TXN
Alert me
Texas Instruments Incorporated 10-K filed Feb 6, 2026
Red flags
-
Impairment
Texas Instruments Incorporated recorded a goodwill impairment of $32.0 million in fiscal 2025
What changed
Item 1, Business, against the 10-K filed Feb 14, 2025: 3 added · 7 removed · 19 modified; 5 with only figures updated
-
Modified
The second element of our strategy to maximize free cash flow per share growth is disciplined allocation of capital. This spans how we select R&D projects, develop new capabilities, invest in manufacturing capacity or how we think about acquisitions and returning cash to our owners. Over a 10-year period from
20152016 to20242025, we allocated $101109 billion, which reinforces the importance of discipline in capital allocation. The largest allocation over this period was to drive organic growth, which includes investments in R&D, sales and marketing, capital expenditures and working capital for inventory. In this period, we allocated about $2024 billion to capital expenditures. Our increased capital expenditures areto support future revenue growth, which will be a greater component of free cash flow per share growth going forward, as we are near completion of our six-year elevated capital expenditures cycle. Beyond that, we also allocated capital to dividends and share repurchases. Dividends are designed to appeal to a broad set of investors, and share repurchases are made with the goal of the accretive capture of future free cash flow for long-term investors. Lastly, for inorganic growth, weallocate toconsider acquisitions that meet our financial and strategic objectives.